KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Cash from Investing Activities: 2017-2025

Historic Cash from Investing Activities for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to -$101.0 million.

  • Elanco Animal Health's Cash from Investing Activities fell 108.12% to -$101.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$305.0 million, marking a year-over-year decrease of 125.14%. This contributed to the annual value of $1.2 billion for FY2024, which is 785.21% up from last year.
  • Elanco Animal Health's Cash from Investing Activities amounted to -$101.0 million in Q3 2025, which was down 80.36% from -$56.0 million recorded in Q2 2025.
  • Over the past 5 years, Elanco Animal Health's Cash from Investing Activities peaked at $1.2 billion during Q3 2024, and registered a low of -$441.0 million during Q3 2021.
  • Its 3-year average for Cash from Investing Activities is $70.4 million, with a median of -$43.0 million in 2023.
  • Per our database at Business Quant, Elanco Animal Health's Cash from Investing Activities crashed by 390.00% in 2022 and then skyrocketed by 3,555.56% in 2024.
  • Over the past 5 years, Elanco Animal Health's Cash from Investing Activities (Quarterly) stood at -$74.0 million in 2021, then declined by 2.70% to -$76.0 million in 2022, then skyrocketed by 53.95% to -$35.0 million in 2023, then tumbled by 157.14% to -$90.0 million in 2024, then slumped by 108.12% to -$101.0 million in 2025.
  • Its last three reported values are -$101.0 million in Q3 2025, -$56.0 million for Q2 2025, and -$58.0 million during Q1 2025.